Plasma AR and docetaxel for metastatic castration-resistant prostate cancer

Attard, G; Conteduca, V; Jayaram, A; Romero-Laorden, N; Wetterskog, D; Salvi, S; Gurioli, G; ... de Giorgi, U; + view all Attard, G; Conteduca, V; Jayaram, A; Romero-Laorden, N; Wetterskog, D; Salvi, S; Gurioli, G; Scarpi, E; Castro, E; Marin-Aguilera, M; Lolli, C; Schepisi, G; Maugeri, A; Wingate, A; Farolfi, A; Casadio, V; Medina, A; Puente, J; Méndez Vidal, MJ; Morales-Barrera, R; Villa-Guzmán, JC; Hernando, S; Rodriguez-Vida, A; González-del-Alba, A; Mellado, B; Gonzalez-Billalabeitia, E; Olmos, D; de Giorgi, U; - view fewer (2018) Plasma AR and docetaxel for metastatic castration-resistant prostate cancer. European Urology (In press).

https://ift.tt/2Q83LSs